Pharmacogenetics of cardiovascular drug therapy. - Wikidata - wikimedia - TriplyDB

Pharmacogenetics of cardiovascular drug therapy.

Pharmacogenetics of cardiovascular drug therapy.

http://www.wikidata.org/entity/Q37430401

about

Effect of AGTR1 and BDKRB2 gene polymorphisms on atorvastatin metabolism in a Mexican population.

P2860

Q47110674-59F7E2DF-8C40-4CEA-A57E-097E2D2D3026

P2860

Pharmacogenetics of cardiovascular drug therapy.

http://www.wikidata.org/entity/Q37430401

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacogenetics of cardiovascular drug therapy.

@en

Pharmacogenetics of cardiovascular drug therapy.

@nl

type

label

Pharmacogenetics of cardiovascular drug therapy.

@en

Pharmacogenetics of cardiovascular drug therapy.

@nl

prefLabel

Pharmacogenetics of cardiovascular drug therapy.

@en

Pharmacogenetics of cardiovascular drug therapy.

@nl

P1433

Q37430401-47187C33-CF95-4962-B413-B610C6C747F3

P1476

Q37430401-25C423F9-3167-4D86-8530-CFEE1205B7F5

P2093

Q37430401-0489C125-D5F7-41CF-950C-791771621F06

Q37430401-2F4153B2-8344-4453-99B9-93FB35169B19

Q37430401-6C3798CA-1451-4482-8907-A826E0DCF027

Q37430401-7DC8489A-D250-407E-ABF8-1F8F5972057B

Q37430401-B3ED962F-7F49-4CA2-8B83-74AAD22EF919

P2860

Q37430401-02145A00-CF32-4D50-8935-649ADC08E3EB

Q37430401-04529550-A6F6-410D-980D-E9624F42765F

Q37430401-06F5F9BC-D646-4069-9495-E5A48832B7E4

Q37430401-0B552328-00F2-4684-9B31-A069C09BE113

Q37430401-0DFA7DB0-6A66-4009-B906-CF102B027EB7

Q37430401-0EE4E146-25DF-4EBB-BD86-8D8DE87851C1

Q37430401-0F7678C7-5816-4C78-A51F-FC67418C7FEF

Q37430401-102C2889-2A2D-4CA7-9D41-6A1CE47B7E3F

Q37430401-10F8AED2-F662-48DC-BB54-0C1AEACE3692

Q37430401-11FB198F-3227-43F4-B127-5BD7039E817A

P304

Q37430401-8FF43AAD-5022-49C3-B541-EF064F43327F

P31

Q37430401-CC4FEAE9-2D7C-4F87-87E1-452CAA9AFA3C

P433

Q37430401-3A897046-970A-457F-92FF-4C5578A4DE22

P478

Q37430401-B0AC8F57-BAD2-425A-A3D1-B412126F8D6C

P577

Q37430401-9ACBB4AE-9694-4CA4-BEDD-3B7DBF7E5089

P698

Q37430401-DFD54A2B-D025-4DFB-9612-44219C9E2BAD

P932

Q37430401-BF762B4D-BDA1-4C5C-8911-83B303E9E0B0

P1433

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases

P1476

Pharmacogenetics of cardiovascular drug therapy.

@en

P2093

Anke-Hilse Maitland-van der Zee

http://www.w3.org/2001/XMLSchema#string

Anthonius de Boer

http://www.w3.org/2001/XMLSchema#string

Bas J M Peters

http://www.w3.org/2001/XMLSchema#string

Bruno H Ch Stricker

http://www.w3.org/2001/XMLSchema#string

Olaf H Klungel

http://www.w3.org/2001/XMLSchema#string

P2860

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk

Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms

PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation

The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy

The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis

Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey

P304

55-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22461099

http://www.w3.org/2001/XMLSchema#string

P932

2781215

http://www.w3.org/2001/XMLSchema#string